456 related articles for article (PubMed ID: 30781775)
1. Folic Acid and Vitamin B12 Administration in CKD, Why Not?
Capelli I; Cianciolo G; Gasperoni L; Zappulo F; Tondolo F; Cappuccilli M; La Manna G
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781775
[TBL] [Abstract][Full Text] [Related]
2. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.
Angelini A; Cappuccilli ML; Magnoni G; Croci Chiocchini AL; Aiello V; Napoletano A; Iacovella F; Troiano A; Mancini R; Capelli I; Cianciolo G
G Ital Nefrol; 2021 Aug; 38(4):. PubMed ID: 34469084
[TBL] [Abstract][Full Text] [Related]
3. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
4. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
5. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
Birn H
Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
[TBL] [Abstract][Full Text] [Related]
6. Vitamin B12 and chronic kidney disease.
Wu HHL; Wang AY
Vitam Horm; 2022; 119():325-353. PubMed ID: 35337625
[TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
Polkinghorne KR; Zoungas S; Branley P; Villanueva E; McNeil JJ; Atkins RC; McGrath BP; Kerr PG
Intern Med J; 2003 Nov; 33(11):489-94. PubMed ID: 14656250
[TBL] [Abstract][Full Text] [Related]
8. Therapy of hyperhomocysteinemia in end-stage renal disease patients.
Hagen W; Födinger M; Hörl WH; Sunder-Plass-Mann G
Minerva Urol Nefrol; 2001 Sep; 53(3):159-70. PubMed ID: 11723441
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Hong SY; Yang DH; Chang SK
Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
[TBL] [Abstract][Full Text] [Related]
11. Effect of Vitamin B
Li Y; Spence JD; Wang X; Huo Y; Xu X; Qin X
Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
[TBL] [Abstract][Full Text] [Related]
12. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
Tungkasereerak P; Ong-ajyooth L; Chaiyasoot W; Ong-ajyooth S; Leowattana W; Vasuvattakul S; Vareesangthip K; Shayakul C; Chanchairujira T; Sritippayawan S
J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
[TBL] [Abstract][Full Text] [Related]
13. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine Modification in Protein Structure/Function and Human Disease.
Jakubowski H
Physiol Rev; 2019 Jan; 99(1):555-604. PubMed ID: 30427275
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery.
Cappuccilli M; Bergamini C; Giacomelli FA; Cianciolo G; Donati G; Conte D; Natali T; La Manna G; Capelli I
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32349312
[TBL] [Abstract][Full Text] [Related]
17. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
[TBL] [Abstract][Full Text] [Related]
18. Association of MTHFR and RFC1 gene polymorphism with hyperhomocysteinemia and its modulation by vitamin B12 and folic acid in an Indian population.
Sukla KK; Raman R
Eur J Clin Nutr; 2012 Jan; 66(1):111-8. PubMed ID: 21878957
[TBL] [Abstract][Full Text] [Related]
19. [Public health control of hyperhomocysteinemia and its consequences].
Czeizel E; Kalina A
Orv Hetil; 2003 Oct; 144(40):1981-9. PubMed ID: 14626640
[TBL] [Abstract][Full Text] [Related]
20. [Determination and utilisation of the plasmatic concentration of homocysteine in clinical practice].
Llevadot J; Blanco Vaca F; González Sastre F
Med Clin (Barc); 2005 Apr; 124(14):544-53. PubMed ID: 15847753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
